infections, respiratory tract
Showing 1 - 17 of 17
Otitis Media, Infections, Respiratory Tract, Respiratory Tract Infections Trial in India (Augmentin (ES)-600)
Completed
- Otitis Media
- +2 more
- Augmentin (ES)-600
-
Raipur, Chhattisgarh, India
- +12 more
Nov 30, 2022
Infections, Respiratory Tract Trial in Erfurt (FluimucilĀ® 2% solution, Acetylcysteine 2% solution)
Completed
- Infections, Respiratory Tract
- FluimucilĀ® 2% solution
- Acetylcysteine 2% solution
-
Erfurt, Thueringen, GermanyGSK Investigational Site
Jan 23, 2019
Infections, Respiratory Tract Trial (Paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C)
Withdrawn
- Infections, Respiratory Tract
- Paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C
- (no location specified)
Mar 9, 2018
Infections, Respiratory Tract Trial (Paracetamol, phenylephrine HCl, and vitamin C)
Withdrawn
- Infections, Respiratory Tract
- Paracetamol, phenylephrine HCl, and vitamin C
- (no location specified)
Mar 9, 2018
Infections, Respiratory Tract Trial (400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml)
Completed
- Infections, Respiratory Tract
- 400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml
- (no location specified)
Aug 2, 2017
Infections, Respiratory Tract Trial in United States (amoxicillin/clavulanate potassium)
Completed
- Infections, Respiratory Tract
- amoxicillin/clavulanate potassium
-
Little Rock, Arkansas
- +5 more
Jul 31, 2017
Infections, Respiratory Tract Trial in London (GSK2140944 for Injection, GSK2140944 Capsule)
Completed
- Infections, Respiratory Tract
- GSK2140944 for Injection
- GSK2140944 Capsule
-
London, United KingdomGSK Investigational Site
Jul 10, 2017
Infections, Respiratory Tract Trial in Austin (GSK2140944, GSK2140944 , Moxifloxacin)
Completed
- Infections, Respiratory Tract
- GSK2140944
- +3 more
-
Austin, TexasGSK Investigational Site
Jul 10, 2017
Infections, Respiratory Tract Trial (Cephalexin 1g tablets)
Completed
- Infections, Respiratory Tract
- Cephalexin 1g tablets
- (no location specified)
Jul 5, 2017
Infections, Respiratory Tract Trial (Cephalexin 125 mg/5ml)
Completed
- Infections, Respiratory Tract
- Cephalexin 125 mg/5ml
- (no location specified)
Jun 21, 2017
Infections, Respiratory Tract Trial in Minneapolis (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Minneapolis, MinnesotaGSK Investigational Site
Jun 9, 2017
Infections, Respiratory Tract Trial (Cephalexin 125 mg/5ml, Cephalexin 250mg/5ml)
Completed
- Infections, Respiratory Tract
- Cephalexin 125 mg/5ml
- Cephalexin 250mg/5ml
- (no location specified)
Jun 2, 2017
Infections, Respiratory Tract Trial in Overland Park (GSK1325756 Solution, GSK1325756 Solution Matching Placebo, GSK1325756
Completed
- Infections, Respiratory Tract
- GSK1325756 Solution
- +3 more
-
Overland Park, KansasGSK Investigational Site
May 12, 2017
Infections, Respiratory Tract Trial in Overland Park (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Overland Park, KansasGSK Investigational Site
May 5, 2017
Infections, Respiratory Tract Trial in Randwick (Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose
Completed
- Infections, Respiratory Tract
- Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose to be determined
- Part B: GSK2140944 Repeat Drug dose of 400mg, 750mg, 1000 mg, and dose to be determined
-
Randwick, New South Wales, AustraliaGSK Investigational Site
May 5, 2017
Program Retrospective Chart Review Study
Completed
- Infections, Respiratory Tract
- retrospective chart review
- (no location specified)
Nov 21, 2016
Infections, Respiratory Tract Trial in Lviv (L. acidophilus DDS-1, B. lactis UABLA-12, Placebo)
Completed
- Infections, Respiratory Tract
- L. acidophilus DDS-1, B. lactis UABLA-12
- Placebo
-
Lviv, UkraineLviv City Children Hospital
Dec 25, 2013